VentiRx Pharmaceuticals Employee Directory
BiotechnologyNew Jersey, United States11-50 Employees
VentiRx Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing immunotherapies that target Toll-like Receptor 8 (TLR8) for cancer, respiratory, and inflammatory diseases, supported by a broad clinical pipeline. Its lead oncology asset, VTX-2337, is a small-molecule TLR8 agonist being evaluated in multiple clinical trials in combination with chemotherapies and monoclonal antibodies, and the company has a worldwide collaboration with Celgene Corporation to advance this program. Based in Summit, New Jersey, the company operates within the biotechnology research sector. Its activities are centered on advancing a broad clinical pipeline and pursuing strategic partnerships to move its programs forward.